Home » Topics » BioWorld Science

BioWorld Science
RSS

ABX-CBL evaluated in phase II GVHD trial

Jan. 7, 1998

Astra to launch new tablet formulation of Losec in Sweden

Jan. 7, 1998

Theratechnologies to begin clinical testing of leukemia Rx

Jan. 7, 1998

NIH contemplates licensing ophthalmic technology to GenVec

Jan. 7, 1998

Cell Genesys to receive milestone payment from HMR for GA-EPO

Jan. 7, 1998

Antitussive properties of Chinoin xanthine explored

Jan. 7, 1998

Spleen ultrafiltrate imparts favorable effects in chemotherapy recipients

Jan. 7, 1998

FDA clears new Allegra product; Seldane to be withdrawn

Jan. 7, 1998

PLC Systems submits requested data related to Heart Laser PMA

Jan. 7, 1998

Faulding establishes new U.S. division, regains rights to Kadian

Jan. 7, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...